Navigation Links
Pre-Clinical Imaging (In Vivo) Market worth $1.55 Billion by 2017 - New Report by MarketsandMarkets
Date:12/27/2013

(PRWEB) December 27, 2013

The report "Global Pre-clinical Imaging (In vivo) Market By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT Multimodality/Hybrid Imaging Modalities] - Competitive Analysis Global Forecasts to 2017" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 117 market data tables and 20 figures through 270 pages and in-depth TOC of "Pre-Clinical Imaging (In vivo) Market."
http://www.marketsandmarkets.com/Market-Reports/pre-clinical-molecular-imaging-market-841.html

Early buyers will receive 10% customization on this report.

Inquire before buying at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=841.

This report studies the global pre-clinical imaging (in vivo) market over the forecast period of 2012-2017.

The global pre-clinical imaging (in vivo) market is broadly segmented into two categories, namely, imaging systems and imaging reagents, and is expected to grow at a CAGR of 14.5% from 2012 to 2017. Imaging systems can be divided into standalone imaging systems and multimodal imaging systems. Standalone imaging systems are further classified into nuclear imaging, optical imaging, Micro-MRI, Micro-CT and Micro-Ultrasound. Multimodal imaging systems are classified into multimodal nuclear imaging devices and multimodal optical imaging devices. Imaging reagents can be divided into nuclear imaging agents, optical imaging agents, MRI contrasting reagents, CT contrast reagents and ultrasound contrast reagents.

The global pre-clinical imaging (in vivo) market has witnessed challenging and dynamic market conditions over the last couple of years, and is valued at $789.4 million in 2012 with an estimated annual growth rate of 14.5% over the next five years. Pre-clinical in vivo imaging industry has experienced myriad technological advancements, changes in the market due to industry consolidation, and change in government funding and support for research studies across the globe over the past decade.

It is expected that the trend of product development and modification will continue in the future to solve the present challenges and unmet needs of the market. Market displays growing preference for hybrid technologies such as SPECT+CT and PET + CT. This trend is expected for novel combination systems such as SPECT + MRI and PET + MRI. The global pre-clinical imaging (in vivo) market is expected to show growth over the long term due to driving factors such as technological advancements, growing adoption rate for pre-clinical imaging, rising application of functional imaging and increasing number of pharma companies and research institutions.

Browse Related Reports
Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/small-animal-imaging-market-957.html

Veterinary Vaccines & Animal Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/medical-devices
Connect with us on LinkedIn at http://www.linkedin.com/company/marketsandmarkets.

Read the full story at http://www.prweb.com/releases/pre-clinical-molecular/imaging-market/prweb11449849.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pre-clinical data shows Angiocidin effective against leukemia
2. Botanisol™, A Glendale-Based High-Tech Firm Applies for $250,000 Grant to Create High-Paying Research Associate Jobs and Complete Pre-Clinical Development
3. MAPCs Bring Lasting Improvements After Brain Injury, Pre-Clinical Study Finds
4. Live imaging shows response to cancer drugs can be boosted by altering tumor microenvironment
5. MR enterography is as good or better than standard imaging exams for pediatric Crohns patients
6. Use of dedicated pediatric imaging departments for pediatric CT reduces radiation dose
7. Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma
8. Study examines necessity of additional imaging in PET/CT oncologic reports
9. Fox Chase researchers find no disparities in imaging before breast cancer surgery
10. Piramal imaging to present data at Society for Nuclear Medicine Annual Meeting
11. Mount Sinai is first in New York state to perform new Alzheimers imaging test in clinical setting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: